• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

NIDCR's Spring 2021 E-Newsletter
Having trouble viewing this email? View it as a Web page. NIDCR's Spring 2021 E-Newsletter In this issue: NIDCR News Funding Opportunities & Related Notices NIH/HHS News Subscribe to NICDR News Science Advances   Grantee News   NIDCR News NIDCR & NIH Stand Against Structural Racism NIDCR Director Rena D’Souza, DDS, MS, PhD, said in a statement that there is no place for structural racism in biomedical research, echoing remarks from NIH Director Francis Collins, MD, PhD, in his announcement of a new NIH initiative—called UNIT...
Source: NIDCR Science News - April 7, 2021 Category: Dentistry Source Type: news

Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial
Conclusions In early, methotrexate-refractory rheumatoid arthritis, a treatment strategy commencing with addition of infliximab, as compared to sulfasalazine+hydroxychloroquine, was not cost-effective over 21 months at willingness to pay levels generally considered acceptable. Trial registration number: NCT00764725.
Source: Annals of the Rheumatic Diseases - May 8, 2015 Category: Rheumatology Authors: Eriksson, J. K., Karlsson, J. A., Bratt, J., Petersson, I. F., van Vollenhoven, R. F., Ernestam, S., Geborek, P., Neovius, M. Tags: Open access, Immunology (including allergy), Connective tissue disease, Degenerative joint disease, Musculoskeletal syndromes, Rheumatoid arthritis, Health economics Clinical and epidemiological research Source Type: research

Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?
Conclusions The mean annual cost in patients with established RA, and mean monthly cost in newly diagnosed patients with RA, were 2–3 times higher than in the general population.
Source: Annals of the Rheumatic Diseases - March 5, 2015 Category: Rheumatology Authors: Eriksson, J. K., Johansson, K., Askling, J., Neovius, M. Tags: Immunology (including allergy), Connective tissue disease, Degenerative joint disease, Musculoskeletal syndromes, Rheumatoid arthritis, Health economics Clinical and epidemiological research Source Type: research

Evolution of cost structures in rheumatoid arthritis over the past decade
Conclusions The increase in treatment costs for RA over the last decade was associated with lower hospitalisation rates, better functional status and a lower incidence of work disability, offsetting a large proportion of risen drug costs. Since the rise in drug costs has manifested a plateau from 2009 onwards, no relevant further increase in total costs for patients with RA treated in German rheumatology is expected.
Source: Annals of the Rheumatic Diseases - March 5, 2015 Category: Rheumatology Authors: Huscher, D., Mittendorf, T., von Hinuber, U., Kotter, I., Hoese, G., Pfafflin, A., Bischoff, S., Zink, A., for the German Collaborative Arthritis Centres Tags: Open access, Immunology (including allergy), Connective tissue disease, Degenerative joint disease, Musculoskeletal syndromes, Rheumatoid arthritis, Health economics Clinical and epidemiological research Source Type: research

The outcome and cost-effectiveness of nurse-led care in people with rheumatoid arthritis: a multicentre randomised controlled trial
Conclusions The results provide robust evidence to support non-inferiority of NLC in the management of RA. Trial registration ISRCTN29803766
Source: Annals of the Rheumatic Diseases - October 5, 2014 Category: Rheumatology Authors: Ndosi, M., Lewis, M., Hale, C., Quinn, H., Ryan, S., Emery, P., Bird, H., Hill, J. Tags: Open access, Immunology (including allergy), Connective tissue disease, Degenerative joint disease, Musculoskeletal syndromes, Rheumatoid arthritis, Epidemiology, Health economics Clinical and epidemiological research Source Type: research